U.S. Black-owned tech firm Better Life Technologies Group, Inc. has been awarded a patent for its wristband or smartwatch used for non-invasive detection of glucose and pathogens, including COVID-19 and any variant, according to Black News.
It may have applications for non-invasive cancer detection, the outlet said.
“The application for this technology is endless. Better Life is now ready to manufacture, sell, or partner with an IP firm to positively impact the healthcare system throughout the world. So we are pivoting to allow outside IP firms to participate in this revolutionary technology,” George McKinney, the founder and CEO of the company, said.
“The goal of this transition is to develop the market-ready version of our technology which we believe could seriously curb the infectiousness of COVID. This version will be fully miniaturized and contain all the necessary wireless communication capabilities,” he added.
The company plans to obtain FDA approval and all the market certifications. It would also like to market a version of its technology that does not require FDA approval. It will be a licensable product that can be mass-produced.
“For this phase, it’s imperative that we are partnered with an entity that can not only fund development monetarily but also assists with development technically,” McKinney said.
According to Black News, this stage will quicken the creation of additional patents. There are three steps involved in this stage — miniaturization, validation and going to market, which will be done in partnership with IP development firms that can move this process forward, McKinney said.
“Finally, to sum it up, their device will detect the specific signature of any chemical composition in the human body ie., cancer, magnesium, calcium, hormonal levels,” Black News said. This will be done through the firm’s newly developed proprietary method of detecting gases as they are emitted from the epidermal layer of the skin.
All in all, Better Life’s device or glucose diagnostic system will be good news for people who fear needles at doctor’s appointments, and the elderly who have problems finding veins.